SureTrader
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

CLDX RSS Feed
Add CLDX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/22/2018 2:44:16 AM - Followers: 101 - Board type: Free - Posts Today: 1

 

 

 Celldex Therapeutics, Inc. (CLDX)

 

slider-images-2

 slider-images-3
http://www.celldextherapeutics.com
 

 

 
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
 
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
 
Management: 
http://www.celldextherapeutics.com/about/management.php
 
 
Product Pipeline: 
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
 
 
News and Press Releases: 
http://ir.celldextherapeutics.com/releases.cfm
 
http://finance.yahoo.com/q/h?s=CLDX+Headlines

 

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 
 
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
 
 
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
 
 
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
 
 
Share Structure:
See SEC filings
 
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com


----------------------------------------------

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 

yes November 8, 2016  yes

 



http://www.fool.com/investing/2016/11/07/premium-celldex-therapeutics-inc-q3-results.aspx?source=djc&utm_campaign=article&utm_medium=feed&utm_source=djc


From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 

yesyesyesyesyesyesyesyesyesyesyesyesyesyes



--------------------------------------------
 

 
 

 

  


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

 

SureTrader
CLDX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
CLDX News: Confidential Treatment Order (ct Order) 04/20/2018 11:04:20 AM
CLDX News: Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018 04/20/2018 08:01:00 AM
CLDX News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 04/19/2018 04:05:47 PM
CLDX News: Current Report Filing (8-k) 04/16/2018 07:02:16 AM
CLDX News: Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint 04/16/2018 07:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1561   CLDX is a buy. Sorry for your loss! lvhd 04/22/18 02:44:16 AM
#1560   One last thing, look at a 3 year harry crumb 04/21/18 09:58:15 PM
#1559   RS is next for this pos company, there harry crumb 04/21/18 09:54:00 PM
#1558   * * $CLDX Video Chart 04-20-18 * * ClayTrader 04/20/18 04:24:59 PM
#1557   Data from Multiple Celldex Programs Presented at American ProfitScout 04/20/18 09:33:00 AM
#1556   Nice! Buy and hold. GL lvhd 04/19/18 02:53:54 PM
#1555   Agree They still have a very reasonable pipeline with LasNubes 04/19/18 02:47:49 PM
#1554   Still looking for a bottom. GMONEY4 04/19/18 09:54:23 AM
#1553   Starter here. Way oversold. lvhd 04/19/18 09:44:20 AM
#1552   Getting cheaper. Let's see if .70 holds. GMONEY4 04/18/18 01:24:14 PM
#1551   Waiting for a firm bottom before getting in Chunky Salsa 04/18/18 01:04:45 PM
#1550   * * $CLDX Video Chart 04-16-18 * * ClayTrader 04/16/18 04:14:25 PM
#1549   By friday this will be .25! Or lower! harry crumb 04/16/18 03:28:06 PM
#1548   About to bounce to what? Lmao, its done, harry crumb 04/16/18 03:25:16 PM
#1547   There were signs of negativity as insiders were harry crumb 04/16/18 03:03:47 PM
#1546   Alright, but what's in the pipeline of worth? Virgilio 04/16/18 01:50:28 PM
#1545   About to bounce.................. Pegaso 04/16/18 01:03:28 PM
#1544   Downgraded to junk.... used to be a good erehdogmai 04/16/18 12:59:41 PM
#1543   Good for a nice bounce.........wait and see....... Pegaso 04/16/18 12:57:38 PM
#1542   Nothing of any value imo. This management team harry crumb 04/16/18 12:56:18 PM
#1541   What's left in the pipeline? Anyone minds to discuss? Virgilio 04/16/18 12:48:08 PM
#1540   Good luck. Shorts will start to cover soon............ Pegaso 04/16/18 12:39:48 PM
#1539   This company absolutely has nothing worthy anymore. Far harry crumb 04/16/18 12:38:00 PM
#1538   Cheap.............geting in now............. Pegaso 04/16/18 12:21:41 PM
#1537   Celldex close to bottom........ Pegaso 04/16/18 12:17:16 PM
#1536   Its junk now. Sold out of everything. Most harry crumb 04/16/18 12:13:24 PM
#1535   Seems cheap .77 but what does the future silvergun 04/16/18 12:11:37 PM
#1534   Junk, out of this turd! harry crumb 04/16/18 12:03:13 PM
#1533   Bummer Harry! Sorry for your loss on this cdaniel394 04/16/18 11:07:09 AM
#1532   On watch. 62% discount. GMONEY4 04/16/18 11:04:14 AM
#1531   It's too bad about the trial results. noretreat 04/16/18 07:53:25 AM
#1530   1’s 2014shelby 04/06/18 06:02:37 PM
#1529   I’m thinking of adding too, all we have clietz 04/05/18 12:08:28 PM
#1528   Added more, 1positive catalyst an cldx awakens to harry crumb 04/05/18 03:04:01 AM
#1527   Yes but we were already at lows. clietz 04/04/18 12:50:10 PM
#1526   Have you been watching the market the past Keithz 04/04/18 11:30:07 AM
#1525   Does anyone know when to expect trial results? clietz 04/03/18 09:56:38 PM
#1524   Getting close to 1’s 2014shelby 04/02/18 08:29:48 PM
#1523   This dog been dead for a long time mack1 03/21/18 02:00:24 PM
#1522   Its very possible. News does wonders to a harry crumb 03/21/18 12:02:47 PM
#1521   It could be $30, it could be $1. clietz 03/20/18 07:28:46 PM
#1520   Harry, do you think they could see $30 Keithz 03/19/18 11:35:12 AM
#1519   This company has a huge pipeline of catalysts harry crumb 03/16/18 11:27:38 PM
#1517   * * $CLDX Video Chart 03-08-18 * * ClayTrader 03/08/18 05:01:54 PM
#1516   Bring on the bacon!! Nice pop. Now if erehdogmai 03/08/18 01:54:16 PM
#1515   Trial results! harry crumb 03/08/18 11:08:12 AM
#1514   So what's the next catalyst for CLDX and Keithz 03/07/18 12:26:06 PM
#1513   If 1’s hit, we will buy 10x our harry crumb 02/14/18 09:19:24 PM
#1512   Gonna wait until 1's hit to add any 2014shelby 02/14/18 08:19:01 PM
#1511   Great post, Added here to, cost average down harry crumb 02/13/18 11:09:12 PM
PostSubject